IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Sarraf Gentile
- Burns Charest
- Andrus Anderson
- K&L Gates
- Tarter Krinsky
- McCune Law
- Gustafson Gluek
- Fiddler Gonzalez
- Cleary Gottlieb
- Stevens & Lee
- Stueve Siegel
- Kirkland & Ellis
- Arnold & Porter
- Patterson Belknap
- Ahern and Associates
- Sills Cummis
- Spiro Harrison
- Harkins Cunningham
- Axinn Veltrop
- King & Spalding
- McDermott Will & Schulte
- Royer Cooper
- Kohn Swift
- Rule Garza
- Morrison & Foerster
- Debevoise & Plimpton
- Kaplan Fox
- Armstrong Teasdale
- Lewis Brisbois
- Levin Sedran
- Barnes & Thornburg
- Tostrud Law Group
- NastLaw
- Gross & Belsky
- Kabat Chapman
- Tycko & Zavareei
- Skadden Arps
- Freedman Boyd
- Buchanan Ingersoll
- Earp Cohn
- Steyer Lowenthal
- Zelle LLP
- Cera LLP
- Garwin Gerstein
- Gibson Dunn
- Krantz & Berman
- Lockridge Grindal
- Edelson Lechtzin
- Grabar Law
- Rosenn Jenkins
- Barrack Rodos
- Pogust Goodhead
- Anselmi & Carvelli
- Saiber LLC
- Cuneo Gilbert
- Welsh & Recker
- DeCotiis FitzPatrick
- Berry Law LLC
- Motley Rice
- Pendley Baudin
- Zwerling Schachter
- Joseph Saveri Law Firm
- Competition Law Partners
- Cole Schotz
- Faegre Drinker
- DLA Piper
- Fox Rothschild
- Morgan Lewis
- Norton Rose
- Polsinelli PC
- Seeger Weiss
- Goodwin Procter
- Venable LLP
- Baker Botts
- Steptoe LLP
- Larson King
- Winston & Strawn
- Barrett Law Group
- McConnell Valdes
- Safirstein Law
- Robbins Geller
- Neufeld Scheck
- WilmerHale
- Spector Roseman
- Neal & Harwell
- Foley & Lardner
- Goldman Scarlato
- Heins Mills
- Hach Rose Schirripa
- Faruqi & Faruqi
- Greenberg Traurig
- Linklaters LLP
- Schertler Onorato
- Fenwick & West
- White & Case
- Wiggin & Dana
- Shinder Cantor
- Stradley Ronon
- Crowell & Moring
- Wexler Boley
- Roberts Law Firm US
- Baker & Hostetler
- Duane Morris
- Freshfields
- Kasowitz Benson
- White and Williams
- Walsh Pizzi
- Boni Zack
- Haynes Boone
- Girard Sharp
- Lyden Chappell
- Hagens Berman
- Bonsignore Trial Lawyers
- Cozen O'Connor
- Napoli Shkolnik
- Carella Byrne
- Schneider Wallace
- Rosca Scarlato
- McCracken Stemerman
- Wisner Baum
- Manatt Phelps
- George Feldman
- Bailey Duquette
- Hogan Lovells
- Ballard Spahr
- Calcaterra Pollack
- Segal McCambridge
- Scott&Scott
- Reed Smith
- Pashman Stein
- Francis Mailman
- DiCello Levitt
- O'Melveny & Myers
- Williams & Connolly
- Nussbaum Law Group
- Bailey & Glasser
- Weil Gotshal
- Lieff Cabraser
- Wilson Sonsini
- Kelley Drye
- Butler Reichline
- Dugan Law Firm
- Marks O'Neill
- Blank Rome
- Shapiro Arato
- Langer Grogan
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Hausfeld LLP
- Kralowec Law
- Furth Salem
- Hangley Aronchick
- Pullman & Comley
- Vinson & Elkins
- Dilworth Paxson
- Yarborough Law Firm
- Bartlit Beck
- Obermayer Rebmann
- Troutman
- Zuckerman Spaeder
- Wolf Haldenstein
- Cotchett Pitre
- Lowenstein Sandler
- Paul Weiss
- Lowey Dannenberg
- Steven Williams Law
- Taus Cebulash
- Bingham McCutchen
- Dechert LLP
- Seward & Kissel
- Hughes Hubbard
- Simpson Thacher & Bartlett LLP
- Miller & Chevalier
- Lite DePalma
- Berman Tabacco
- Boies Schiller
- Radice Law Firm
- Whatley Kallas
- Cohen Milstein
- Proskauer Rose
- O’Neill & Borges
- Sperling Kenny
- Clark Hill
- Miller Shah
- Zimmerman Reed
- Berger Montague
- Susman Godfrey
- Glancy Prongay
- Alston & Bird
- Gordon Rees
- Constantine Cannon
- Harris St. Laurent
- Shipman & Goodwin
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Haug Partners
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
Companies
- Albertsons Cos. Inc.
- Sun Pharmaceutical Industries Ltd.
- J.M. Smith Corp.
- Perrigo Co. PLC
- Humana Inc.
- Impax Laboratories, Inc.
- McKesson Corp.
- Blue Cross Blue Shield Association
- MSP Recovery
- Walgreens Boots Alliance Inc.
- Endo International PLC
- Bausch Health Cos. Inc.
- Sandoz International GmbH
- Cencora Inc.
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- Walmart Inc.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Lannett Company, Inc
- Health Care Service Corp.
- Glenmark Pharmaceuticals Ltd.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- The Cigna Group
- Hi-Tech Pharmacal Co., Inc.
- Red Oak Sourcing LLC
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Florida Blue
- Viatris Inc.
- Aetna Inc.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- Centene Corp.
- G&W Laboratories Inc.
- The Kroger Co.
- Upsher-Smith Laboratories Inc.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- Novartis AG
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
May 16, 2024
$5.5M Apotex Generic Drug Price-Fixing Deal Gets Initial OK
A Pennsylvania federal judge gave preliminary approval to yet another settlement in the sweeping generic drug price-fixing multidistrict litigation, this time signing off on pharmaceutical company Apotex's $5.5 million settlement with clinics, hospitals and independent pharmacies.
-
April 02, 2024
Healthcare In Court: Idaho AG Not 'Cute' On Abortion Ban
Idaho's solicitor general had a hard day at the Ninth Circuit, where a panel tried and failed to get a lock on the state attorney general's stance on Idaho's abortion ban. Home Depot pressed the U.S. Supreme Court to review a $2.67 billion settlement in antitrust litigation against the Blue Cross Blue Shield Association. And in Texas, a woman charged with murder for inducing her own abortion sued the prosecutors behind the case.
-
March 27, 2024
NY AG, Others Blast Sandoz Deal 'Tax' On Future Settlements
New York's attorney general was one of three objectors Tuesday to a provision in Sandoz's proposed $265 million settlement with a class of drug wholesalers in Pennsylvania federal court that they say will delay any future generic-drug price-fixing litigation deals by taxing agreements over $119.25 million.
-
March 14, 2024
Drug Wholesalers Want Preliminary OK On $265M Sandoz Deal
A group of direct purchasers of generic drugs has asked a Pennsylvania federal court for approval of a $265 million settlement with Swiss drugmaker Sandoz over allegations of federal antitrust violations.
-
February 29, 2024
Sandoz To Pay $265M To Resolve Claims In Price-Fixing MDL
Swiss generic drug and biosimilar manufacturer Sandoz announced Thursday that two of its subsidiaries have reached a $265 million settlement with the direct purchasers of generic medications to resolve allegations of federal antitrust violations.
-
February 14, 2024
Settlements of 3 Drug Cos. Get Prelim OK In Price-Fixing MDL
A Pennsylvania federal judge granted preliminary approval Wednesday to settlements in which two makers and one distributor of generic drugs agreed to pay a combined $45 million to resolve allegations they colluded to fix the prices of medications, including those used to treat glaucoma, high blood pressure and high cholesterol.
-
February 01, 2024
State-Led Generic Drug Cases Removed From MDL
The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.
-
January 23, 2024
3 Generic-Drug Cos. Reach Settlements In Price-Fixing MDL
Generic-drug makers Apotex Corp., Heritage Pharmaceuticals Ltd. and Breckenridge Pharmaceutical Inc. have each agreed to shell out a combined $45 million to settle allegations they colluded to fix the prices of many medications, according to a trio of motions filed Tuesday in multidistrict litigation in Pennsylvania federal court.
-
January 17, 2024
Generic-Drug Cos. Say States Are Mum In MDL Discovery
Generic-drug makers steeped in antitrust multidistrict litigation are asking for an order enforcing a months-old deadline for documents that most states have ignored, according to a memorandum filed in Pennsylvania federal court.
-
December 07, 2023
Generics Price-Fixing Cases Should Stay In MDL, Judge Says
The Pennsylvania federal judge overseeing sprawling multidistrict litigation against generic-drug makers on Thursday told the U.S. Judicial Panel on Multidistrict Litigation that she does not recommend transferring state enforcer actions out of the MDL yet, saying there's more the court can do to get the cases ready for trial or to tee up settlement talks.